|
Risk factor
|
Univariate analysis
|
Multivariate analysis
|
|---|
|
OR (95% CI)
|
p
|
aOR (95% CI)
|
p
|
|---|
|
Age > 65 years
|
6.33 (1.66–24.10)
|
< 0.001
|
4.23 (1.39–12.89)
|
0.007
|
|
Autoimmune etiology of cirrhosis
|
8.50 (1.39–12.89)
|
0.006
|
3.88 (0.82–6.22)
|
0.08
|
|
Antibiotic use in the previous 7 days
|
3.30 (1.16–9.37)
|
0.002
|
2.66 (0.91–3.08)
|
0.29
|
|
Cephalosporin prophylaxis
|
4.70 (1.18–18.70)
|
0.001
|
3.61 (1.81–17.24)
|
0.04
|
|
Hepatic encephalopathy
|
3.38 (1.22–9.41)
|
< 0.001
|
4.99 (1.44–17.30)
|
0.01
|
|
BUN
|
1.08 (1.00–1.61)
|
0.01
|
1.01 (1.00–1.03)
|
0.14
|
|
Serum ferritin
|
1.01 (1.01–1.87)
|
0.04
|
0.84 (0.47–1.68)
|
0.62
|
- This table presents risk factors associated with developement of MDR HA-UTI. MDR Multi-drug resistant, HA Hospital acquired, UTI Urinary tract infection, OR Odds ratio, CI Confidence interval, aOR Adjusted odds ratio, BUN Blood urea nitrogen
